Coupang Inc. (NYSE: CPNG): Deutsche Bank downgraded the shares to Hold from Buy and has a $20 target price. The consensus target is $21.79. The stock closed 8% higher on Wednesday at $19.30 after earnings beat estimates.
Datadog Inc. (NASDAQ: DDOG): Stifel’s downgrade to Hold from Buy included a target price cut to $90 from $115. The consensus target is $106.32. Wednesday’s closing share price was $86.76.
Dish Network Corp. (NASDAQ: DISH): Barclays upgraded the stock to Equal Weight from Underweight. The analyst also raised the $5 target price to $10, though the consensus target is $15.98 for now. The stock closed on Wednesday at $8.27.
DraftKings Inc. (NASDAQ: DKNG): J.P. Morgan upgraded the shares to Neutral from Underweight and has a $26 target price. The consensus target is $35.29. The shares closed on Wednesday at $28.26, down almost 11% for the day due to the Disney/Penn Gaming deal.
Eli Lilly and Co. (NYSE: LLY): As Jefferies upgraded the stock to Buy from Hold, its $408 target price jumped to $615. The consensus target is $495.49. Wednesday’s close was at $526.23.
GlobalFoundries Inc. (NASDAQ: GFS): Morgan Stanley reiterated an Overweight rating but trimmed its $80 target price to $73. Deutsche Bank reiterated a Buy rating and lowered its target to $65 from $70. The consensus target is $72.13, and shares closed on Wednesday at $59.21.
International Flavors & Fragrances Inc. (NYSE: IFF): When Goldman Sachs downgraded the stock to Neutral from Buy, the $120 target price dropped to $78. The consensus target is $98.16 for now. Wednesday’s close was at $63.78. The company cut full-year sales guidance earlier this week.
LivePerson Inc. (NASDAQ: LPSN): Craig Hallum upgraded the stock to Buy from Hold. Its $7 target price is well above the $4.81 consensus target. The stock closed almost 20% higher on Wednesday at $4.75, after the upgrade and the company posted earnings and revenue that surpassed estimates.
Mirati Therapeutics Inc. (NASDAQ: MRTX): The B. Riley Securities upgrade was from Neutral to Buy with a $45 target price. The consensus target is $57.53 for now. Wednesday’s $37.00 close was up 33% for the day on positive clinical data, the CEO’s departure and the upgrade.
Novavax Inc. (NASDAQ: NVAX): The Neutral rating at B. Riley Securities is now at Buy, but the $15 target price is less than the $21.40 consensus target. Wednesday’s close was at $7.12.
Nvidia Corp. (NASDAQ: NVDA): Stifel reiterated its Hold rating. The analyst also boosted its $370 target price to $440, though the consensus target is $454.40. The stock closed almost 5% lower on Wednesday at $425.54.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
